Normal range (serum): 510-2,040 mcg/mL
51 The Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) trial reported that tirzepatide (10 mg or 15 mg) significantly reduced the apnoeahypopnea index in people with moderate to severe obstructive sleep apnoea and obesity
But long-term safety should be monitored by a healthcare provider, particularly if you have underlying conditions or take medications that interact
Preclinical studies describe its role in supporting tissue repair processes, including effects on muscle, tendon, ligament, and gastrointestinal tissues
Based on information from related drugs, this medication may pass into breast milk
Copper Toxicity: Although transdermal patches hardly ever cause copper toxicity, you should nevertheless take the recommended dosage as advised on the bottle